by
Anonymous
January 14, 2004 - UTrackSys.com LLC released the UTS Diabetes 1.0 for Palm OS. The new software provides the complete way of diabetes management with PDA. It keeps track of blood glucose level, insulin injections, carbohydrates consumed and various medication intakes.
http://www.utracksys.com/plugins/diabetes/
The UTS Diabetes unites all features of specialized software that serves as a traditional paper Diabetic's logbook. Plus, it has a lot of original outstanding features:
- Unique interfaces to enter readings without Graffiti and without keyboard.
- Recording glucose measurements both in mg/dL and in mmol/L.
- Calculation of insulin and medication doses required for lowering the high blood glucose.
- Colored records for dangerous, normal and optimal blood glucose level.
- Insulin tracking with predefined and yet customizable list of insulin types.
- Medications tracking with predefined and yet customizable list of common diabetic medicines.
- Carbohydrates tracking with predefined and yet customizable list of meals.
- Interactive charts: Diagrams and Histograms.
- Summarized reports with Min, Max and Averages.
- List filtering capabilities.
- Ability to e-mail diabetes reports to the doctor from the Palm.
- Export to MemoPad.
- Windows conduit to export the data onto desktop PC into MS Excel.
All beta-testers and premium users who got the UTS Diabetes before the official release had rated it on the average as 9.4 points out of 10.
The UTS Diabetes costs $14.95 per copy. To give the diabetics the full set of software for managing their health, the company also created the UTS Diabetic Kit. This bundle includes four products: Universal Tracking System, UTS Blood Pressure, UTS Weight, and UTS Diabetes plug-ins. It has value of $55, but the special discount of $20 allows ordering the UTS Diabetic Kit for just $34.80.
The free trials are available for downloading at
http://www.utracksys.com/download/getfile.php?product=utsdt
This article courtesy of http://www.diabetesinc.net.
You may freely reprint this article on your website
or in your newsletter provided this courtesy notice
and the author name and URL remain intact.
